49085-4
First and Second trimester integrated maternal screen panel
Active
Term Description
The Integrated screen requires two specimens. The first specimen collected between 11-13 weeks' gestation determines Choriogonatotropin and Pregnancy associated plasma protein A levels. The second specimen is the second trimester Quad screen. The integrated screen yield the best detection rate and lowest false-positive rate of all prenatal screens.
Panel Hierarchy
Details for each LOINC in Panel LHC-Forms
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 49085-4 | First and Second trimester integrated maternal screen panel | |||
| Indent49086-2 | First trimester maternal screen with nuchal translucency panel | |||
| Indent Indent49087-0 | Maternal screen clinical predictors panel | |||
| Indent Indent Indent30525-0 | Age | R-a | a | |
| Indent Indent Indent43993-5 | Age at delivery | O | a | |
| Indent Indent Indent11778-8 | Delivery date Estimated | O | ||
| Indent Indent Indent11977-6 | [#] Parity | O | {#} | |
| Indent Indent Indent11996-6 | [#] Pregnancies | O | {#} | |
| Indent Indent Indent21484-1 | Mother's race | O | ||
| Indent Indent Indent21112-8 | Birth date | O | {mm/dd/yyyy} | |
| Indent Indent Indent29463-7 | Body weight | O | [lb_av];kg | |
| Indent Indent Indent32624-9 | Race | O | ||
| Indent Indent Indent18185-9 | Gestational age | O | wk | |
| Indent Indent Indent21299-3 | Gestational age method | O | ||
| Indent Indent Indent11878-6 | Number of fetuses by US | O | {#} | |
| Indent Indent Indent8665-2 | Last menstrual period start date | O | {date} | |
| Indent Indent Indent34970-4 | Ultrasound date | O | ||
| Indent Indent Indent33248-6 | Diabetes status [Identifier] | O | ||
| Indent Indent Indent44877-9 | Insulin dependent diabetes mellitus [Presence] | O | ||
| Indent Indent Indent49053-2 | History of Neural tube defect Narrative | O | ||
| Indent Indent Indent68327-6 | Egg donor age | a | ||
| Indent Indent Indent68328-4 | Previous fetus defect | |||
| Indent Indent19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma | O | m[IU]/mL | |
| Indent Indent20465-1 | Choriogonadotropin [Multiple of the median] in Serum or Plasma | R | {M.o.M} | |
| Indent Indent32166-1 | Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent48407-1 | Pregnancy associated plasma protein A [Mass/volume] in Serum or Plasma | O | ng/mL | |
| Indent Indent32123-2 | Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma | R | {M.o.M} | |
| Indent Indent43995-0 | Trisomy 21 risk [Likelihood] in Fetus | R | {risk} | |
| Indent Indent49030-0 | Trisomy 21 risk based on maternal age+Pregnancy associated plasma protein A+Choriogonadotropin+Nuchal translucency [Likelihood] in Fetus | |||
| Indent Indent49090-4 | Fetal Trisomy 21 risk [Likelihood] Based on maternal age | O | {risk} | |
| Indent Indent49582-0 | Trisomy 18 risk cutoff in Fetus | O | ||
| Indent Indent47223-3 | Fetal Trisomy 18 risk [Likelihood] Based on maternal age | O | {risk} | |
| Indent Indent49583-8 | Trisomy 21 risk cutoff in Fetus | O | ||
| Indent Indent43994-3 | Trisomy 18 risk [Likelihood] in Fetus | R | {risk} | |
| Indent Indent50679-0 | First trimester maternal screen with nuchal translucency [Interpretation] | O | ||
| Indent Indent11957-8 | Fetal Crown Rump length US | R | cm | |
| Indent Indent33069-6 | Fetal nuchal translucency measured by US | R | mm | |
| Indent Indent49089-6 | Sonographer [Identifier] | R | ||
| Indent Indent49088-8 | Sonographer name | R | ||
| Indent48800-7 | Second trimester quad maternal screen panel - Serum or Plasma | |||
| Indent Indent49087-0 | Maternal screen clinical predictors panel | |||
| Indent Indent Indent30525-0 | Age | R-a | a | |
| Indent Indent Indent43993-5 | Age at delivery | O | a | |
| Indent Indent Indent11778-8 | Delivery date Estimated | O | ||
| Indent Indent Indent11977-6 | [#] Parity | O | {#} | |
| Indent Indent Indent11996-6 | [#] Pregnancies | O | {#} | |
| Indent Indent Indent21484-1 | Mother's race | O | ||
| Indent Indent Indent21112-8 | Birth date | O | {mm/dd/yyyy} | |
| Indent Indent Indent29463-7 | Body weight | O | [lb_av];kg | |
| Indent Indent Indent32624-9 | Race | O | ||
| Indent Indent Indent18185-9 | Gestational age | O | wk | |
| Indent Indent Indent21299-3 | Gestational age method | O | ||
| Indent Indent Indent11878-6 | Number of fetuses by US | O | {#} | |
| Indent Indent Indent8665-2 | Last menstrual period start date | O | {date} | |
| Indent Indent Indent34970-4 | Ultrasound date | O | ||
| Indent Indent Indent33248-6 | Diabetes status [Identifier] | O | ||
| Indent Indent Indent44877-9 | Insulin dependent diabetes mellitus [Presence] | O | ||
| Indent Indent Indent49053-2 | History of Neural tube defect Narrative | O | ||
| Indent Indent Indent68327-6 | Egg donor age | a | ||
| Indent Indent Indent68328-4 | Previous fetus defect | |||
| Indent Indent1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma | O | ng/mL | |
| Indent Indent20450-3 | Alpha-1-Fetoprotein [Multiple of the median] in Serum or Plasma | R | {M.o.M} | |
| Indent Indent49585-3 | Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma | O | {M.o.M} | |
| Indent Indent23811-3 | Alpha-1-Fetoprotein [Multiple of the median] adjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent43998-4 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes in Serum or Plasma | O | {M.o.M} | |
| Indent Indent43996-8 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for diabetes+weight in Serum or Plasma | O | {M.o.M} | |
| Indent Indent50610-5 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for multiple gestations in Serum or Plasma | O | {M.o.M} | |
| Indent Indent43997-6 | Alpha-1-Fetoprotein [Multiple of the median] adjusted for weight in Serum or Plasma | O | {M.o.M} | |
| Indent Indent23812-1 | Alpha-1-Fetoprotein [Multiple of the median] unadjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma | O | m[IU]/mL | |
| Indent Indent20465-1 | Choriogonadotropin [Multiple of the median] in Serum or Plasma | R | {M.o.M} | |
| Indent Indent32166-1 | Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent2250-9 | Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma | O | ng/mL | |
| Indent Indent20466-9 | Estriol (E3).unconjugated [Multiple of the median] in Serum or Plasma | R | {M.o.M} | |
| Indent Indent21264-7 | Estriol (E3).unconjugated [Multiple of the median] adjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent21265-4 | Estriol (E3).unconjugated [Multiple of the median] unadjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent23883-2 | Inhibin A [Mass/volume] in Serum or Plasma | O | pg/L | |
| Indent Indent35738-4 | Inhibin A [Multiple of the median] in Serum or Plasma | R | {M.o.M} | |
| Indent Indent36904-1 | Inhibin A [Multiple of the median] adjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent36905-8 | Inhibin A [Multiple of the median] unadjusted in Serum or Plasma | O | {M.o.M} | |
| Indent Indent48803-1 | Neural tube defect risk [Likelihood] in Fetus | R | % | |
| Indent Indent43994-3 | Trisomy 18 risk [Likelihood] in Fetus | R | {risk} | |
| Indent Indent47223-3 | Fetal Trisomy 18 risk [Likelihood] Based on maternal age | O | {risk} | |
| Indent Indent49582-0 | Trisomy 18 risk cutoff in Fetus | O | ||
| Indent Indent43995-0 | Trisomy 21 risk [Likelihood] in Fetus | R | {risk} | |
| Indent Indent49090-4 | Fetal Trisomy 21 risk [Likelihood] Based on maternal age | O | {risk} | |
| Indent Indent49583-8 | Trisomy 21 risk cutoff in Fetus | O | ||
| Indent Indent49092-0 | Second trimester quad maternal screen [Interpretation] in Serum or Plasma Narrative | O | ||
| Indent49586-1 | First and Second trimester integrated maternal screen [Interpretation] | O | ||
| Indent75365-7 | First and Second trimester integrated maternal screen [Interpretation] Narrative | O |
LOINC Names Get Info
- Fully-Specified Name
- First & Second trimester integrated maternal screen panel:
-: Pt: ^Patient: -: - Long Common Name
- First and Second trimester integrated maternal screen panel
- Short Name
- Integrated scn Pnl Patient
- Display Name
- First and Second trimester integrated maternal screen panel
- Consumer Name Alpha Get Info
- First and Second trimester integrated maternal Screen panel
Part Model Get Info
- Component
- First & Second trimester integrated maternal screen panel
LP69870-1
- Analyte
- First & Second trimester integrated maternal screen panel
LP69870-1
- Component Numerator
- First & Second trimester integrated maternal screen panel
LP69870-1
- Component Numerator Core
- First & Second trimester integrated maternal screen panel
LP69870-1
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- -
LP6769-6
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- -
LP7747-1
- Method
- NULL
Basic Attributes
- Class
- PANEL.CHEM
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Order
- Common Test Rank Get Info
- 6820
- Panel Type
- Panel
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Těhotenský screening v prvním a druhém trimestru integrovaný panel: |
| el-GR | Greek (Greece) | Ολοκληρωμένος πίνακας μητρικών εξετάσεων διαλογής πρώτου και δεύτερου τριμήνου: Synonyms: - CHEM PANEL.CHEM Pt Ασθενής Ολοκληρωμένες μητρικές εξετάσεις διαλογής πρώτου και δεύτερου τριμήνου Ολοκληρωμένος πίνακας μητρικών εξετάσεων διαλογής πρώτου και δεύτερου τριμήνου |
| es-ES | Spanish (Spain) | Panel de cribado materno integrado del primer y segundo trimestre: |
| es-MX | Spanish (Mexico) | Panel de pantalla materna integrado en el primer y segundo trimestre: |
| et-EE | Estonian (Estonia) | Sünnieelne kromosoomihaiguste integreeritud riskihinnang I ja II trimestril: Synonyms: Juhuslik |
| fr-CA | French (Canada) | Dépistage maternel intégré, premier et deuxième trimestres panel: |
| fr-FR | French (France) | Dépistage maternel au cours des 1er et 2nd trimestre de grossesse panel: |
| fr-BE | French (Belgium) | Screening maternel. Profil intégré Trimestre I et Trimestre II: |
| it-IT | Italian (Italy) | Primo e Secondo trimestre, panel di screening materno integrato: Synonyms: Chimica Panel screening materno integrato del Primo e Seco paziente Punto nel tempo (episodio) Screening materno integrato del Primo e Secondo tr Set di prescrizione chimica |
| nl-NL | Dutch (Netherlands) | eerste & tweede trimester integrale maternale screening panel: |
| pl-PL | Polish (Poland) | Pierwszy & Drugi trymestr ciąży zintegrowany panel badań przesiewowych matki: Synonyms: Zintegrowany panel badań przesiewowych matki w pierwszym i drugim trymestrze ciąży Zintegrowany test przesiewowy matki w pierwszym i drugim trymestrze ciąży |
| pt-BR | Portuguese (Brazil) | Primeiro+segundo trimestre maternidade integrado painel: Synonyms: ; |
| ru-RU | Russian (Russian Federation) | Первый & Второй триместр интегрированный мать скрин панель: Synonyms: Точка во времени; |
| zh-CN | Chinese (China) | 早期妊娠与中期妊娠整体孕妇筛查组套: Synonyms: 2nd 化学; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=49085-4 - Questionnaire definition
- https:
//fhir.loinc.org/Questionnaire/?url=http: //loinc.org/q/49085-4
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://